chr3-52457855-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_007184.4(NISCH):ā€‹c.106C>Gā€‹(p.Gln36Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000363 in 1,459,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.000036 ( 0 hom. )

Consequence

NISCH
NM_007184.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.24
Variant links:
Genes affected
NISCH (HGNC:18006): (nischarin) This gene encodes a nonadrenergic imidazoline-1 receptor protein that localizes to the cytosol and anchors to the inner layer of the plasma membrane. The orthologous mouse protein has been shown to influence cytoskeletal organization and cell migration by binding to alpha-5-beta-1 integrin. In humans, this protein has been shown to bind to the adapter insulin receptor substrate 4 (IRS4) to mediate translocation of alpha-5 integrin from the cell membrane to endosomes. Expression of this protein was reduced in human breast cancers while its overexpression reduced tumor growth and metastasis; possibly by limiting the expression of alpha-5 integrin. In human cardiac tissue, this gene was found to affect cell growth and death while in neural tissue it affected neuronal growth and differentiation. Alternative splicing results in multiple transcript variants encoding differerent isoforms. Some isoforms lack the expected C-terminal domains of a functional imidazoline receptor. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12114066).
BS2
High AC in GnomAdExome4 at 53 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NISCHNM_007184.4 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/21 ENST00000345716.9 NP_009115.3 Q9Y2I1-1
NISCHNM_001276293.2 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/13 NP_001263222.2 Q9Y2I1
NISCHNM_001276294.2 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/14 NP_001263223.2 Q9Y2I1-4
NISCHXM_047447373.1 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/18 XP_047303329.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NISCHENST00000345716.9 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/211 NM_007184.4 ENSP00000339958.4 Q9Y2I1-1
NISCHENST00000479054.5 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 3/221 ENSP00000418232.1 Q9Y2I1-1
NISCHENST00000488380.5 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/131 ENSP00000417812.1 C9J715
NISCHENST00000420808.2 linkuse as main transcriptc.106C>G p.Gln36Glu missense_variant 2/145 ENSP00000392484.2 Q9Y2I1-4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.0000363
AC:
53
AN:
1459290
Hom.:
0
Cov.:
30
AF XY:
0.0000400
AC XY:
29
AN XY:
725510
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000468
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
33
Bravo
AF:
0.0000113
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 19, 2024The c.106C>G (p.Q36E) alteration is located in exon 2 (coding exon 2) of the NISCH gene. This alteration results from a C to G substitution at nucleotide position 106, causing the glutamine (Q) at amino acid position 36 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
20
DANN
Benign
0.92
DEOGEN2
Benign
0.068
T;T;.;.
Eigen
Benign
-0.20
Eigen_PC
Benign
0.075
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.90
.;D;D;D
M_CAP
Benign
0.0041
T
MetaRNN
Benign
0.12
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.57
N;N;.;N
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.63
N;N;N;N
REVEL
Benign
0.061
Sift
Benign
0.29
T;T;T;T
Sift4G
Benign
0.35
T;T;T;T
Polyphen
0.065
B;B;B;.
Vest4
0.32
MVP
0.12
MPC
0.46
ClinPred
0.67
D
GERP RS
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.51
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs373680961; hg19: chr3-52491871; API